Dow Up 0.07% Nasdaq Up 0.61%

More On ENTB

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Entest Biomedical, Inc. (ENTB)

-Other OTC
0.00 Nov 26, 1:14PM EST
|Pre-Market : NaN
Prev Close:0.00
Open:N/A
Bid:2.40 x 500
Ask:3.50 x 500
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.01 - 2.25
Volume:0
Avg Vol (3m):N/A
Market Cap:198.91K
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Entest Biomedical, Inc. develops and commercializes immunotherapeutic therapies for the veterinary market. The company is developing ImenVax family of canine cancer vaccines, which include ImenVax I, a therapeutic for canine cancer that is involve... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback